BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 24680817)

  • 21. The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation.
    Campden RI; Zhang Y
    Arch Biochem Biophys; 2019 Jul; 670():32-42. PubMed ID: 30807742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple roles for cysteine cathepsins in cancer.
    Joyce JA; Hanahan D
    Cell Cycle; 2004 Dec; 3(12):1516-619. PubMed ID: 15539953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages.
    Punturieri A; Filippov S; Allen E; Caras I; Murray R; Reddy V; Weiss SJ
    J Exp Med; 2000 Sep; 192(6):789-99. PubMed ID: 10993910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Future of Cysteine Cathepsins in Disease Management.
    Kramer L; Turk D; Turk B
    Trends Pharmacol Sci; 2017 Oct; 38(10):873-898. PubMed ID: 28668224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cysteine cathepsin activity regulation by glycosaminoglycans.
    Novinec M; Lenarčič B; Turk B
    Biomed Res Int; 2014; 2014():309718. PubMed ID: 25587532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines.
    Repnik U; Starr AE; Overall CM; Turk B
    J Biol Chem; 2015 May; 290(22):13800-11. PubMed ID: 25833952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic potential of targeting cathepsin S in pulmonary fibrosis.
    Yoo Y; Choi E; Kim Y; Cha Y; Um E; Kim Y; Kim Y; Lee YS
    Biomed Pharmacother; 2022 Jan; 145():112245. PubMed ID: 34772578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases.
    Wu H; Du Q; Dai Q; Ge J; Cheng X
    J Atheroscler Thromb; 2018 Feb; 25(2):111-123. PubMed ID: 28978867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer.
    Edgington-Mitchell LE; Rautela J; Duivenvoorden HM; Jayatilleke KM; van der Linden WA; Verdoes M; Bogyo M; Parker BS
    Oncotarget; 2015 Sep; 6(29):27008-22. PubMed ID: 26308073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cysteine cathepsins as therapeutic targets in inflammatory diseases.
    Vizovišek M; Vidak E; Javoršek U; Mikhaylov G; Bratovš A; Turk B
    Expert Opin Ther Targets; 2020 Jun; 24(6):573-588. PubMed ID: 32228244
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of elastolytic cathepsins in human skin and their involvement in age-dependent elastin degradation.
    Panwar P; Hedtke T; Heinz A; Andrault PM; Hoehenwarter W; Granville DJ; Schmelzer CEH; Brömme D
    Biochim Biophys Acta Gen Subj; 2020 May; 1864(5):129544. PubMed ID: 32007579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
    Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
    J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges.
    Brix K; McInnes J; Al-Hashimi A; Rehders M; Tamhane T; Haugen MH
    Protoplasma; 2015 May; 252(3):755-74. PubMed ID: 25398648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Cysteine Protease Cathepsins B, H, C, and X/Z in Neurodegenerative Diseases and Cancer.
    Stoka V; Vasiljeva O; Nakanishi H; Turk V
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic Identification of Cysteine Cathepsin Substrates Shed from the Surface of Cancer Cells.
    Sobotič B; Vizovišek M; Vidmar R; Van Damme P; Gocheva V; Joyce JA; Gevaert K; Turk V; Turk B; Fonović M
    Mol Cell Proteomics; 2015 Aug; 14(8):2213-28. PubMed ID: 26081835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates.
    Li Z; Hou WS; Brömme D
    Biochemistry; 2000 Jan; 39(3):529-36. PubMed ID: 10642177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cysteinyl cathepsins: multifunctional enzymes in cardiovascular disease.
    Li X; Liu Z; Cheng Z; Cheng X
    Chonnam Med J; 2012 Aug; 48(2):77-85. PubMed ID: 22977747
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Yadati T; Houben T; Bitorina A; Shiri-Sverdlov R
    Cells; 2020 Jul; 9(7):. PubMed ID: 32668602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational predictions of cysteine cathepsin-mediated fibrinogen proteolysis.
    Ferrall-Fairbanks MC; West DM; Douglas SA; Averett RD; Platt MO
    Protein Sci; 2018 Mar; 27(3):714-724. PubMed ID: 29266558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unveiling the Roles of Cysteine Proteinases F and W: From Structure to Pathological Implications and Therapeutic Targets.
    Zdravkova K; Mijanovic O; Brankovic A; Ilicheva PM; Jakovleva A; Karanovic J; Pualic M; Pualic D; Rubel AA; Savvateeva LV; Parodi A; Zamyatnin AA
    Cells; 2024 May; 13(11):. PubMed ID: 38891048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.